(Q74591199)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9602254%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

0 references

1 reference

title

What is the role of erythropoietin in patients with solid tumours? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9602254%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

author name string

A Maraveyas

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9602254%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

R Pettengell

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9602254%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

publication date

1 March 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9602254%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9602254%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

volume

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9602254%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9602254%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

page(s)

239-241

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9602254%20AND%20SRC:MED&resulttype=core&format=json

Decreased erythropoietin response in patients with the anemia of cancer

11 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008273032715

7 January 2021

Recombinant human erythropoietin treatment in cisplatin-associated anemia: a randomized, double-blind trial with placebo

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008273032715

7 January 2021

Treatment of chemotherapy-induced anemia with recombinant human erythropoietin in cancer patients

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008273032715

7 January 2021

Recombinant human erythropoietin for the correction of cancer associated anemia with and without concomitant cytotoxic chemotherapy.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008273032715

7 January 2021

Recombinant human erythropoietin therapy for anemic cancer patients on combination chemotherapy

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008273032715

7 January 2021

Quality of life in chronic anemia of cancer during treatment with recombinant human erythropoietin.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008273032715

7 January 2021

Impact of therapy with epoetin alfa on clinical outcomes in patients with nonmyeloid malignancies during cancer chemotherapy in community oncology practice. Procrit Study Group

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008273032715

7 January 2021

Transfusion requirements, risks, and costs for patients with malignancy

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008273032715

7 January 2021

Cost comparison of recombinant human erythropoietin and blood transfusion in cancer chemotherapy-induced anemia

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008273032715

7 January 2021

Recombinant human erythropoietin in the treatment of chemotherapy-induced anemia and prevention of transfusion requirement associated with solid tumors: A randomized, controlled study

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008273032715

7 January 2021

Identifiers

DOI

10.1023/A:1008273032715

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9602254%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

1 reference